EVALUATION OF TWO GENOTYPES OF GUINEA PIGS (Cavia porcellus) FED WITH CONCENTRATED AND EXCLUSION OF FORAGE

El estudio tuvo como objetivo evaluar los parámetros productivos y el porcentaje de grasa en la carcasa de dos genotipos de cuyes (Cavia porcellus) alimentados por nueve semanas con dos tipos de dieta. Se utilizó el diseño estadístico completamente al azar con arreglo factorial 2x2, teniendo como factores dos genotipos (Cieneguilla-UNALM y Perú-INIA) y dos tipos de dietas (dieta 1: alimento balanceado, forraje verde y agua; dieta 2: alimento balanceado más vitamina C y agua), y se evaluó el peso vivo final, ganancia de peso diaria, consumo de alimento, conversión alimenticia, peso y rendimiento de carcasa, y porcentaje de grasa y porcentaje de humedad en la carcasa. El peso vivo final, ganancia de peso, conversión alimenticia y peso de carcasa a las 12 semanas de edad en cuyes del genotipo Cieneguilla fue de 1266 g, 15.6 g/día, 3.14 y 878 g, respectivamente, en tanto que en los cuyes Perú fue de 1154 g, 13.6 g/día, 3.54 y 765 g, respectivamente (p<0.05). El factor genotipo no influyó en el consumo de alimento, rendimiento de carcasa ni el porcentaje de grasa y humedad en la carcasa. Asimismo, ni el tipo de dieta ni la interacción genotipo x tipo de alimentación fueron factores significativos en los parámetros productivos evaluados.The aim of the study was to evaluate the productive performance and percent of fat in the carcass of two guinea pig(Cavia porcellus) genotypes fed for nine weeks with two types of diets. A Randomized Complete Design with 2x2 factorial arrangements was used: two genotypes (Cieneguilla-UNALM and Peru-INIA) and two diets (diet 1: concentrate supplement, forage and water, and diet 2: concentrate supplement with vitamin C and water). The final body weight, daily weight gain, dry matter intake, feed conversion, carcass weight and yield, and fat and moisture percentage of the carcasses were evaluated. The final body weight, body weight gain, feed conversion and carcass weight at 12 weeks of age in Cieneguilla animals was 1266 g, 15.6 g/day, 3.14 and 878 g respectively whereas in Peru animals was 1154 g, 13.6 g/day, 3.54 and 765 g respectively (p<0.05). The genotype did not affect dry mater intake, carcass yield, or fat and moisture percentage. Moreover, neither the type of diet nor the interaction genotype x diet were significant factors affecting the parameters under evaluation

Digestibilidad y energía digestible y metabolizable del gluten de maíz, hominy feed y subproducto de trigo en cuyes (Cavia porcellus)

The aim of this study was to determine the digestibility of dry matter and the digestible and metabolizable energy of the wheat by-product, corn germ and hominy feed by the in vivo digestibility test in guinea pigs, using the technique of total faeces and urine collection. Genetically improved young male guinea pigs (n=15) were distributed in three groups and fed with three diets: a) Basal diet (100% wheat by-product, protected vitamin C and water), b) Mixture I (70% corn germ and 30% basal diet) and Mixture II (70% hominy feed and 30% basal diet). The nutritional values of the diets were determined. The digestibility of corn germ, hominy feed and wheat by-product were 79.0, 81.2 and 65.3%, respectively, digestible energy was 4189, 4372 and 2801 kcal/kg of dry matter, respectively, and metabolizable energy was 3910, 4351 and 2705 kcal/kg of dry matter, respectively.El objetivo del estudio fue determinar la digestibilidad de la materia seca y la energía digestible y metabolizable del subproducto de trigo, germen de maíz y hominy feed mediante el ensayo de digestibilidad in vivo en cuyes, utilizando la técnica de colección total de heces y orina. Se utilizaron 15 cuyes machos jóvenes mejorados distribuidos en tres tratamientos y alimentados con tres dietas: a) Dieta basal (100% de subproducto de trigo, vitamina C protegida y agua), b) Mezcla I (70% de germen de maíz y 30% de dieta basal) y Mezcla II (70% de hominy feed y 30% de dieta basal). Se determinaron los valores nutricionales de las dietas. La digestibilidad del germen de maíz, hominy feed y subproducto de trigo fue de 79.0, 81.2 y 65.3%, respectivamente, la energía digestible fue de 4189, 4372 y 2801 kcal/kg de materia seca, respectivamente y de energía metabolizable fue de 3910, 4351 y 2705 kcal/kg de materia seca, respectivamente

Aplicación de la espectroscopía del infrarrojo cercano – NIRS – para determinar el valor nutritivo de variedades de alfalfa (Medicago sativa L) y trébol rojo (Trifolium pratense L)

The aim of this study was to determine the applicability of near infrared spectroscopy (NIRS) for the nutritional assessment of two important forage species in the country: alfalfa (Medicago sativa L) and red clover (Trifolium pratense L). For this, 75 samples of alfalfa varieties (SW 8210, WL 625HQ) and 75 of red clover varieties (Quiñequeli, Kendland) obtained from the paddocks of the IVITA El Mantaro Experimental Station, Junín region, Peru were used. Proximal analysis was performed determining the content of crude protein (CP), ether extract (EE), crude fibre (CF), total ash (TA) and neutral detergent fibre (NDF), and the spectrum was captured using NIRS equipment. The calibration and validation models were developed to estimate the predictive capacity using Partial Least Squares (PLS), and the accuracy and precision statistics used were the Correlation Coefficient (R), Determination Coefficient (R2), Root Mean Square Error of Calibration (RMSEC), Root Mean Square of Prediction Error (RMSEP), Ratio of Range to Error (RER) and Residual Predictive Deviation (RPD). The mathematical models obtained showed that the NIRS technique has a good predictive capacity for the nutritional components of CP, TA and NDF (R2: 0.97, 0.99, 0.94; RPD: 2.00, 2.17 and 2.00, respectively) for varieties of alfalfa and red clover.El objetivo del presente estudio fue determinar la aplicabilidad de la espectroscopía del infrarrojo cercano (NIRS) para la valoración nutritiva de dos especies forrajeras de importancia en el país: alfalfa (Medicago sativa L) y trébol rojo (Trifolium pratense L). Se utilizaron 75 muestras de variedades de alfalfa (SW 8210, WL 625HQ) y 75 de variedades de trébol rojo (Quiñequeli, Kendland) obtenidas de los campos de la Estación Experimental IVITA El Mantaro, región Junín, Perú. Se realizó el análisis proximal determinando el contenido de proteína cruda (PC), extracto etéreo (EE), fibra cruda (FC), cenizas totales (CZ) y fibra detergente neutra (FDN) y se hizo la captura del espectro mediante un equipo NIRS. Se elaboraron los modelos de calibración y validación para estimar la capacidad predictiva mediante Cuadrados Mínimos Parciales (PLS), siendo los estadísticos de exactitud y precisión usados el Coeficiente de Correlación (R), Coeficiente de Determinación (R2), Raíz Cuadrada Media del Error de Calibración (RMSEC), Raíz Cuadrada Media del Error de Predicción (RMSEP), Proporción del Rango con el Error (RER) y Desviación Residual Predictiva (RPD). Los modelos matemáticos obtenidos muestran que la técnica NIRS posee una capacidad de predicción buena de los componentes nutricionales de PC, CZ y FDN (R2:0.97, 0.99, 0.94; RPD: 2.00, 2.17 y 2.00, respectivamente) para variedades de alfalfa y trébol rojo

FaMYB123 interacts with FabHLH3 to regulate the late steps of anthocyanin and flavonol biosynthesis during ripening.

In this work, we identified and functionally characterized the strawberry (Fragaria × ananassa) R2R3 MYB transcription factor FaMYB123. As in most genes associated with organoleptic properties of ripe fruit, FaMYB123 expression is ripening-related, receptacle-specific, and antagonistically regulated by ABA and auxin. Knockdown of FaMYB123 expression by RNAi in ripe strawberry fruit receptacles downregulated the expression of enzymes involved in the late steps of anthocyanin/flavonoid biosynthesis. Transgenic fruits showed a parallel decrease in the contents of total anthocyanin and flavonoid, especially malonyl derivatives of pelargonidin and cyanidins. The decrease was concomitant with accumulation of proanthocyanin, propelargonidins, and other condensed tannins associated mainly with green receptacles. Potential coregulation between FaMYB123 and FaMYB10, which may act on different sets of genes for the enzymes involved in anthocyanin production, was explored. FaMYB123 and FabHLH3 were found to interact and to be involved in the transcriptional activation of FaMT1, a gene responsible for the malonylation of anthocyanin components during ripening. Taken together, these results demonstrate that FaMYB123 regulates the late steps of the flavonoid pathway in a specific manner. In this study, a new function for an R2R3 MYB transcription factor, regulating the expression of a gene that encodes a malonyltransferase, has been elucidated.This work was funded by the Spanish Ministerio de Ciencia e Innovacion (AGL2014-55784-C2-2-R and AGL2017-86531-C2-2-R). FJMR is supported by a ‘Margarita Salas’ post-doctoral fellowship (UCOR02MS) from the University of Cordoba (Requalification of the Spanish university system) from the Ministry of Universities financed by the European Union (NexGenerationEU). FJMH is supported by a ‘Juan de la Cierva-Incorporacion’ fellowship (IJC2020- 045526-I), funded by MCIN/AEI/10.13039/501100011033 and the European Union ‘NextGenerationEU’/PRTR. AR-F and SA are on the European Union’s Horizon 2020 Research and Innovation Program, Project PlantaSYST (SGA-CSA No. 739582 under FPA No. 664620). The authors thank Dr. Gema Garc ıa from the Microscopy Unit of UCAIB-IMIBIC for technical help with the microscope. Funding for open access charge: University of Cordoba/CBUA.S

Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies

BACKGROUND: Filamin C (encoded by the FLNC gene) is essential for sarcomere attachment to the plasmatic membrane. FLNC mutations have been associated with myofibrillar myopathies, and cardiac involvement has been reported in some carriers. Accordingly, since 2012, the authors have included FLNC in the genetic screening of patients with inherited cardiomyopathies and sudden death. OBJECTIVES: The aim of this study was to demonstrate the association between truncating mutations in FLNC and the development of high-risk dilated and arrhythmogenic cardiomyopathies. METHODS: FLNC was studied using next-generation sequencing in 2,877 patients with inherited cardiovascular diseases. A characteristic phenotype was identified in probands with truncating mutations in FLNC. Clinical and genetic evaluation of 28 affected families was performed. Localization of filamin C in cardiac tissue was analyzed in patients with truncating FLNC mutations using immunohistochemistry. RESULTS: Twenty-three truncating mutations were identified in 28 probands previously diagnosed with dilated, arrhythmogenic, or restrictive cardiomyopathies. Truncating FLNC mutations were absent in patients with other phenotypes, including 1,078 patients with hypertrophic cardiomyopathy. Fifty-four mutation carriers were identified among 121 screened relatives. The phenotype consisted of left ventricular dilation (68%), systolic dysfunction (46%), and myocardial fibrosis (67%); inferolateral negative T waves and low QRS voltages on electrocardiography (33%); ventricular arrhythmias (82%); and frequent sudden cardiac death (40 cases in 21 of 28 families). Clinical skeletal myopathy was not observed. Penetrance was >97% in carriers older than 40 years. Truncating mutations in FLNC cosegregated with this phenotype with a dominant inheritance pattern (combined logarithm of the odds score: 9.5). Immunohistochemical staining of myocardial tissue showed no abnormal filamin C aggregates in patients with truncating FLNC mutations. CONCLUSIONS: Truncating mutations in FLNC caused an overlapping phenotype of dilated and left-dominant arrhythmogenic cardiomyopathies complicated by frequent premature sudden death. Prompt implantation of a cardiac defibrillator should be considered in affected patients harboring truncating mutations in FLNC.Instituto de Salud Carlos III [PI11/0699, PI14/0967, PI14/01477, RD012/0042/0029, RD012/0042/0049, RD012/0042/0066, RD12/0042/0069]; Spanish Ministry of Economy and Competitiveness [SAF2015-71863-REDT]; Plan Nacional de I+D+I; Plan Estatalde I+D+I, European Regional Development Fund; Health in Code SLS

Role of age and comorbidities in mortality of patients with infective endocarditis

[Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis

Giant cell arteritis (GCA) is the most common form of vasculitis in individuals older than 50 years in Western countries. To shed light onto the genetic background influencing susceptibility for GCA, we performed a genome-wide association screening in a well-powered study cohort. After imputation, 1,844,133 genetic variants were analysed in 2,134 cases and 9,125 unaffected controls from ten independent populations of European ancestry. Our data confirmed HLA class II as the strongest associated region (independent signals: rs9268905, P = 1.94E-54, per-allele OR = 1.79; and rs9275592, P = 1.14E-40, OR = 2.08). Additionally, PLG and P4HA2 were identified as GCA risk genes at the genome-wide level of significance (rs4252134, P = 1.23E-10, OR = 1.28; and rs128738, P = 4.60E-09, OR = 1.32, respectively). Interestingly, we observed that the association peaks overlapped with different regulatory elements related to cell types and tissues involved in the pathophysiology of GCA. PLG and P4HA2 are involved in vascular remodelling and angiogenesis, suggesting a high relevance of these processes for the pathogenic mechanisms underlying this type of vasculitis

Analysis of the common genetic component of large-vessel vasculitides through a meta- Immunochip strategy

Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are major forms of large-vessel vasculitis (LVV) that share clinical features. To evaluate their genetic similarities, we analysed Immunochip genotyping data from 1,434 LVV patients and 3,814 unaffected controls. Genetic pleiotropy was also estimated. The HLA region harboured the main disease-specific associations. GCA was mostly associated with class II genes (HLA-DRB1/HLA-DQA1) whereas TAK was mostly associated with class I genes (HLA-B/MICA). Both the statistical significance and effect size of the HLA signals were considerably reduced in the cross-disease meta-analysis in comparison with the analysis of GCA and TAK separately. Consequently, no significant genetic correlation between these two diseases was observed when HLA variants were tested. Outside the HLA region, only one polymorphism located nearby the IL12B gene surpassed the study-wide significance threshold in the meta-analysis of the discovery datasets (rs755374, P?=?7.54E-07; ORGCA?=?1.19, ORTAK?=?1.50). This marker was confirmed as novel GCA risk factor using four additional cohorts (PGCA?=?5.52E-04, ORGCA?=?1.16). Taken together, our results provide evidence of strong genetic differences between GCA and TAK in the HLA. Outside this region, common susceptibility factors were suggested, especially within the IL12B locus